Hongyue Dai

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 3

Top Topics

Transcription Factor

Hodgkin Lymphoma

Top Venues

Cancer research

FASEB bioAdvances

JMIR research protocols

H Lee Moffitt Cancer Center and Research Institute

Institute of High Energy Physics Chinese Academy of Sciences (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

H Lee Moffitt Cancer Center and Research Institute

United States

CBIO :: M2Gen

Education History

Institute of High Energy Physics Chinese Academy of Sciences Sep 01 1984

China

PHD :: Astrophysics

Peking University

China

BSC :: Nuclear Physics

Publications

Karen L Burger, Mario R Fernandez, Mark B Meads, Praneeth Reddy Sudalagunta, Paula S Oliveira, Rafael Renatino Canevarolo, Raghunandan Reddy Alugubelli, Alexandre Tungsevik, Gabe De Avila, Maria Silva, Allison I Graeter, Hongyue Dai, Nicole D Vincelette, Antony Prabhu, Dario Magaletti, Chunying Yang, Weimin Li, Amit Kulkarni, Oliver Alexander Hampton, John M Koomen, William R Roush, Andrii Monastyrskyi, Anders E Berglund, Ariosto S Silva, John L Cleveland, Kenneth H Shain
CK1δ/CK1ε Signaling Sustains Mitochondrial Metabolism and Cell Survival in Multiple Myeloma. Cancer research (2023)
Hongyue Dai, Shan Lou, Yanbo Zhang, Monica Thanawala, Kai-Chih Huang, Lexiang Ji, Sarah Carden, Tiffany Liao, Mandana Abbassi, Chengyi J Shu, Alexandra Lantermann, Masoud Sadaghiani, Daniel Blom, John A Wagner, Pearl Huang
Transcriptional neural-like signaling contributes to an immune-suppressive tumor microenvironment. FASEB bioAdvances 4 (1) (2021)
Bin Li, Steven A Eschrich, Anders E Berglund, Melissa Mitchell, David Fenstermacher, Hadi Danaee, Hongyue Dai, Daniel Sullivan, William L Trepicchio, William S Dalton
Use of the Total Cancer Care System to Enrich Screening for CD30-Positive Solid Tumors for Patient Enrollment Into a Brentuximab Vedotin Clinical Trial: A Pilot Study to Evaluate Feasibility. JMIR research protocols 6 (3) (2017)